Publication | Open Access

Design, synthesis and molecular modeling of biquinoline–pyridine hybrids as a new class of potential EGFR and HER-2 kinase inhibitors

Molecular PharmacologyMedicinal ChemistryHer-2 Kinase InhibitorsBiochemistryMedicineNatural SciencesRational Drug DesignNew ClassHeterocycle ChemistryPharmacologyMolecular ModelingPharmaceutical ChemistryBiquinoline–pyridine HybridsDrug Discovery